# JIN MEDICAL INTERNATIONAL LTD. (ZJYL) fundamentals

Data as of 2026-11-07. NASDAQ, United States. Sector: Healthcare / Medical Devices & Supplies. Price $3.36, market value $535 million.

## Valuation
- **P/E (trailing): 17.7×** (5-yr avg 1663.3×, 3-yr avg 1663.3×). JIN MEDICAL INTERNATIONAL LTD. trades at 17.7× trailing earnings, well below its own five-year average of 1663.3×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×.
- **Price / sales: 25.9×**. Each dollar of revenue is priced at 25.9×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 18.0×**. The shares trade at 18.0× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -0.7%** (5-yr avg -0.0%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 5.7%**. The inverse of the P/E: 5.7% of the price is earned each year.

## Profitability
- **Gross margin: 29.2%**. JIN MEDICAL INTERNATIONAL LTD. keeps 29.2% of revenue after the direct cost of what it sells.
- **Operating margin: 2.9%**. 2.9% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 5.8%**. 5.8% of each dollar of sales reaches the bottom line.
- **Return on equity: 4.0%**. 4.0% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 1.1%**. Return on all capital, debt included, is 1.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.2%**. Each dollar of assets produces 2.2% of profit.

## Growth
- **Revenue growth (1 yr): -12.0%** (3-yr 2.5%/yr). Revenue fell 12.0% over the last year.
- **EPS growth (1 yr): -50.0%** (3-yr -20.6%/yr). Earnings per share fell 50.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.64**. Debt is 0.64 times equity, moderate leverage.
- **Interest coverage: 1.5×**. Operating profit covers interest only 1.5×: fragile.
- **Current ratio: 1.86** (quick 1.86). Current assets cover the next year's liabilities 1.86 times.
- **Altman Z-score: 15.15**. A Z-score of 15.15 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. JIN MEDICAL INTERNATIONAL LTD. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -35.1%** (YTD -23.6%, 3-mo 56.3%). The shares are down 35.1% over twelve months including dividends.
- **From 52-week high: -41.9%** (119.6% above the low). Trading 42% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 76**. An RSI of 76 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.86** (volatility 108%). Beta of 0.86 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ZJYL · Page: https://foliofundamentals.com/stocks/zjyl

Not investment advice.